Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2020.1830286
Abstract: Abstract Background and aims In France, there are approximately 2,400 new cases of neuroendocrine tumors (NETs) annually. Peptide receptor radionuclide therapy with 177Lu-Dotatate plus long-acting repeatable [LAR] octreotide 30 mg has been shown to significantly improve…
read more here.
Keywords:
octreotide lar;
177lu dotatate;
dotatate;
midgut nets ... See more keywords